Señales en vivo de RPHM | Maximiza tus Ganancias con Getagraph.com

COMPRAR 124822 min ago

@ $1.715

Emitido: 9 feb 2024 @ 11:54

Retorno: 1.46%

Señal anterior: feb 9 - 10:42

Señal anterior: Vender

Retorno: 0.42 %

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 16:00):

Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases...

Stats
Volumen de hoy	110 683
Volumen promedio	167 156
Capitalización de mercado	57.96M
EPS	$0 ( 2024-03-25 )
Próxima fecha de ganancias	( $0 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.740
ATR14	$0.00600 (0.35%)

Insider Trading

Date	Person	Action	Amount	type
2023-08-28	Hall Ashley	Sell	15 625	Stock option (right to buy)
2023-08-28	Hall Ashley	Buy	15 625	Common Stock
2023-08-28	Hall Ashley	Sell	15 625	Common Stock
2023-07-26	Grey Michael G	Sell	50 000	Common Stock
2023-06-23	Novo Holdings A/s	Sell	100 000	Common Stock

INSIDER POWER
49.34
Last 95 transactions
Buy: 16 929 845 \| Sell: 55 923 583

Volumen Correlación

Largo: 0.10 (neutral)

Corto: -0.11 (neutral)

Signal:(35.423) Neutral

Reneo Pharmaceuticals, Correlación

10 Correlaciones Más Positivas
PYXS	0.915
FRSX	0.884
XPON	0.867
SGTX	0.851
XOG	0.84
SGEN	0.839
HJLI	0.828
SATS	0.827
NTRA	0.822
STAB	0.821

10 Correlaciones Más Negativas
ALT	-0.872
CERE	-0.85
LMRKN	-0.824
ISTR	-0.815
HOUR	-0.813
BSBK	-0.812
MYFW	-0.807
RNRG	-0.806
CFFN	-0.805
VWE	-0.805

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Reneo Pharmaceuticals, Correlación - Moneda/Commodity

-0.21
( neutral )

-0.45
( neutral )

0.00
( neutral )

-0.61
( weak negative )

0.00
( neutral )

-0.15
( neutral )

Reneo Pharmaceuticals, Finanzas

Annual	2022
Ingresos:	$0
Beneficio Bruto:	$-529 000 (0.00 %)
EPS:	$-2.04

FY	2022
Ingresos:	$0
Beneficio Bruto:	$-529 000 (0.00 %)
EPS:	$-2.04

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-5.11

FY	2020
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-2.50

Financial Reports:

No articles found.

Reneo Pharmaceuticals,

Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as well as in Phase 1b clinical trial in patients with long-chain fatty acid oxidation disorders and glycogen storage disease type V. Reneo Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in San Diego, California.

Actualizaciones en tiempo real para Reneo Pharmaceuticals, [RPHM]

Upcoming Earnings Alert